OrsoBio has announced the publication in Nature Medicine of Phase I clinical trial data for TLC-2716, an oral liver-targeted ...

Multiple sclerosis (MS) is a debilitating disease with few treatment options. But in a new clinical trial, scientists have tested a promising new therapy involving injections of stem cells, which ...

Regene Therapeutics Co., Ltd. ("iRegene" or the "Company"), a biotechnology company pioneering chemically induced allogeneic cell therapy, today announced that its lead product, NouvNeu001, has been ...

Researchers in China have found no statistically significant advantage for infrapatellar fat pad glucocorticoid injection ...

Glucocorticoid injections into the infrapatellar fat pad do not reduce knee pain or effusion synovitis volume in patients ...

The FDA granted fast track status to VectorY’s VTx-002, an antibody gene therapy targeting TDP-43 protein aggregates in ALS.

“For decades, the diabetes world has focused on lowering sugar, not on treating the root cause of the disease nor on stopping its progression” said Dr. Dror Chevion, co-founder and CEO of Concenter ...

New Pharmacokinetic (PK) and Pharmacodynamic Data from Sub-Study in Phase III Trial Strengthens Scientific Basis for RenovoRx ...

SAN ANTONIO – It’s common knowledge that diabetics receive their insulin through injections or pumps. However, many people don’t know of a new option: inhalable insulin. The inhaler called Afrezza, ...

FORT COLLINS, CO - January 15, 2026 - - Institute of Clinical Excellence has highlighted cognitive functional therapy as an evidence-based clinical approach for managing persistent pain, drawing on ...